Search Results 1201-1210 of 16403 for monoclonal antibody

1. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy - Mayo Clinic

   The purpose of this study is to target two autoimmune neurological conditions that we consider proof of principal T cell- and antibody ... antibody titer greater ...

2. Mayo Clinic researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients

   Wadei and his team tested the blood of patients who had received a solid organ for spike antibodies to COVID-19, which would be the type of antibody generated ...

3. A Study of State-Specific Blood Marker Investigation in Bipolar and Schizoaffective Disorder - Mayo Clinic

   The purpose of this study is to find out if some patients with mood symptoms have antibodies (part of the immune system) that affect the brain, and could ...

4. Autoimmune neurology: Enhanced expertise for treatable conditions - Mayo Clinic

   Irani and his team were the first to describe some of these conditions, including LGI1- and CASPR2-antibody encephalitis. ... antibodies. "Mayo Clinic ...

5. A Study to Evaluate AL101 Monotherapy in Patients with Notch Activated Triple Negative Breast Cancer - Mayo Clinic

   Prior treatment with investigational monoclonal antibody will be reviewed case-by-case by the Sponsor. Receiving chronic systemic steroid therapy (in dosing ...

6. A Study of Benralizumab in Patients With Eosinophilic Esophagitis - Mayo Clinic

   ... antibody), or other stable chronic liver disease are acceptable ... Receipt of any marketed or investigational biologic (monoclonal or polyclonal antibody) ...

7. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

8. Advances in lung cancer immunotherapy and management of immune-mediated adverse events - Mayo Clinic

   Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for patients with stage IV non-small cell lung ...

9. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

   For Follicular Lymphoma, patients must have received prior chemoimmunotherapy including an antibody directed against CD20. For Mantle Cell Lymphoma ...

10. A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM - Mayo Clinic

    Chemotherapy, biologic therapy (i.e., small molecular inhibitors), monoclonal antibodies ... antibody on a shorter frequency (i.e., every two weeks), then the ...